AFAP1 and prostate carcinoma: Other proteins enriched in prostate cancer proteins such as LAPTM4A, RAB7A, AFAP, and TSPAN6 are putative targets for CRL1 as detected by screening with a NEDD8 activating enzyme inhibitor [35].